BABA vs DAN

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

Dana Incorporated exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health. Despite a massive 1-year price surge, the company suffers from a negative ROE (-4.27%), an alarmingly high Debt/Equity ratio of 3.94, and a dividend payout ratio of 90.91% that is likely unsustainable. The disconnect between the current price ($38.93) and the earnings track record—where the company has missed estimates in 4 of the last 4 quarters with an average surprise of -41.45%—suggests a momentum-driven bubble rather than value creation.